Rocío López Herrero, Paula Martínez Jiménez, Daniel Ortiz Del Olmo, Rosa Dolores Prieto-Utrera, Rosa Cobo-Zubia, Adrián García Concejo, Mario Lorenzo-López, Irina Rebollo Mato, Fernando Vaquerizo Villar, Rodrigo Poves-Álvarez, Esther Gómez-Sánchez, Eduardo Tamayo
Sepsis epidemiology in Spain was strongly influenced by COVID-19, but the burden remained concentrated among older, multimorbid patients. Stable non-COVID-19 trends highlight a persistent healthcare challenge, undercoring the need for adequate resource planning and clinical management adapted to high-risk population.
OBJECTIVES: To describe trends in incidence, in-hospital mortality, clinical characteristics, infection sources, and healthcare burden of sepsis in Spain from 2017 to 2022, while assessing the impact of COVID-19.
METHODS: We conducted a nationwide, population-based retrospective study using the Spanish Minimum Basic Data Set. Sepsis was identified by concurrent infection and organ dysfunction codes based on Angus criteria adapted for ICD-10-CM. Age-adjusted incidence, in-hospital mortality, healthcare costs, and a non-COVID-19 sepsis cohort were analysed.
RESULTS: Among 1,187,393 sepsis hospitalisations, annual cases increased from 183,971 in 2017 to 226,884 in 2022. Age-adjusted incidence changed from a baseline of approximately 4.0 per 1,000 inhabitants in 2017 to reach 4.65 per 1,000 inhabitants in 2022.. In-hospital mortality increased from an initial19.4% in 2017, peaked at 23.7% in 2020, and stabilised at 20.8% in 2022. Patients were predominantly older adults, with a mean age of 74.3 years and a high metabolic and respiratory comorbidity burden. Respiratory and genitourinary infections were the leading sources. Costs peaked during the pandemic and remained substantial.
CONCLUSIONS: Sepsis epidemiology in Spain was strongly influenced by COVID-19, but the burden remained concentrated among older, multimorbid patients. Stable non-COVID-19 trends highlight a persistent healthcare challenge, undercoring the need for adequate resource planning and clinical management adapted to high-risk population.